Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
BVF PARTNERS L P/IL reported a 9.99% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Eledon Pharmaceuticals, Inc., 7,868,419 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,868,419
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6.80% | 5,382,084 |
| BVF I GP LLC | 6.80% | 5,382,084 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.70% | 2,057,090 |
| BVF II GP LLC | 2.70% | 2,057,090 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 301,588 |
| BVF Partners OS Ltd. | 0.40% | 301,588 |
| BVF GP HOLDINGS LLC | 9.40% | 7,439,174 |
| BVF PARTNERS L P/IL | 9.99% | 7,868,419 |
| BVF INC/IL | 9.99% | 7,868,419 |
| LAMPERT MARK N | 9.99% | 7,868,419 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Bvf Partners L P
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026